JANX

SEC source: 0001864158-26-000006 · form4-07312026_080701.xml · nonDerivative · entry 1

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,742

SEC source: 0001864158-26-000004 · form4-07102026_080702.xml · derivative · entry 2

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 697,550

Underlying: Common Stock · 7,000 shares

Expires 2031-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001864158-26-000004 · form4-07102026_080702.xml · nonDerivative · entry 1

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001863094-26-000002 · form4-06122026_080611.xml · derivative · entry 2

Simson Jake · CIK 0001863094 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F3 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Advisor"), the Reporting Person holds the option and RSUs reported for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Person is obligated to turn over to the Advisor any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Advisor. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock.

SEC source: 0001863094-26-000002 · form4-06122026_080611.xml · nonDerivative · entry 1

Simson Jake · CIK 0001863094 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Advisor"), the Reporting Person holds the option and RSUs reported for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Person is obligated to turn over to the Advisor any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Advisor. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock.

SEC source: 0001231919-26-000631 · form4-06132026_120640.xml · derivative · entry 4

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner

RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner

RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director

Kolchinsky Peter · CIK 0001384859 · Director · 10% owner

Shah Rajeev M. · CIK 0001619841 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F6 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to Dr. Simson's continuous service on each such date.

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.

F3 · ownership.nature: Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option and RSU for the benefit of the Fund and the Nexus Fund II. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and RSUs and underlying common stock.

SEC source: 0001231919-26-000631 · form4-06132026_120640.xml · nonDerivative · entry 1

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner

RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner

RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director

Kolchinsky Peter · CIK 0001384859 · Director · 10% owner

Shah Rajeev M. · CIK 0001619841 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 11,750

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to Dr. Jake Simson's continuous service on such date.

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.

F3 · ownership.nature: Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option and RSU for the benefit of the Fund and the Nexus Fund II. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and RSUs and underlying common stock.

SEC source: 0001666963-26-000003 · form4-06122026_080609.xml · derivative · entry 2

Kung Winston · CIK 0001666963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

SEC source: 0001666963-26-000003 · form4-06122026_080609.xml · nonDerivative · entry 1

Kung Winston · CIK 0001666963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

SEC source: 0001780547-26-000004 · form4-06122026_080607.xml · derivative · entry 2

Hernday Natasha · CIK 0001780547 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

SEC source: 0001780547-26-000004 · form4-06122026_080607.xml · nonDerivative · entry 1

Hernday Natasha · CIK 0001780547 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,481

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

SEC source: 0001202785-26-000002 · form4-06122026_080605.xml · derivative · entry 2

DOBMEIER ERIC · CIK 0001202785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

SEC source: 0001202785-26-000002 · form4-06122026_080605.xml · nonDerivative · entry 1

DOBMEIER ERIC · CIK 0001202785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,481

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

SEC source: 0001248190-26-000002 · form4-06122026_080604.xml · derivative · entry 2

CAPPS VICKIE L · CIK 0001248190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

SEC source: 0001248190-26-000002 · form4-06122026_080604.xml · nonDerivative · entry 1

CAPPS VICKIE L · CIK 0001248190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,598

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

SEC source: 0001326330-26-000002 · form4-06122026_080601.xml · derivative · entry 2

Barrett Ronald W · CIK 0001326330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

SEC source: 0001326330-26-000002 · form4-06122026_080601.xml · nonDerivative · entry 1

Barrett Ronald W · CIK 0001326330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

SEC source: 0002069239-26-000005 · form4-06042026_080601.xml · nonDerivative · entry 1

Doyle Janeen Noel · CIK 0002069239 · Chief Corp. & Bus. Dev. Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,941

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $14.029 and the range of prices were between $13.96 and $14.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002032671-26-000004 · form4-05132026_080505.xml · nonDerivative · entry 1

Dobek Maria · CIK 0002032671 · Vice President, Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,270

SEC source: 0002108554-26-000004 · form4-02052026_010237.xml · derivative · entry 2

Go William · CIK 0002108554 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,000

Underlying: Common Stock · 154,000 shares

Expires 2036-02-01

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on February 26, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0002108554-26-000004 · form4-02052026_010237.xml · nonDerivative · entry 1

Go William · CIK 0002108554 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on February 1, 2027.

SEC source: 0002069239-26-000002 · form4-01022026_090103.xml · derivative · entry 2

Doyle Janeen Noel · CIK 0002069239 · Chief Corp. & Bus. Dev. Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,000

Underlying: Common Stock · 126,000 shares

Expires 2036-01-01

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0002069239-26-000002 · form4-01022026_090103.xml · nonDerivative · entry 1

Doyle Janeen Noel · CIK 0002069239 · Chief Corp. & Bus. Dev. Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0002050056-26-000002 · form4-01022026_090105.xml · derivative · entry 3

McIver Zachariah · CIK 0002050056 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,500

Underlying: Common Stock · 101,500 shares

Expires 2036-01-01

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0002050056-26-000002 · form4-01022026_090105.xml · nonDerivative · entry 2

McIver Zachariah · CIK 0002050056 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,286

F2 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0002050056-26-000002 · form4-01022026_090105.xml · nonDerivative · entry 1

McIver Zachariah · CIK 0002050056 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,286

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

SEC source: 0002032671-26-000002 · form4-01022026_090101.xml · derivative · entry 3

Dobek Maria · CIK 0002032671 · Vice President, Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2036-01-01

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0002032671-26-000002 · form4-01022026_090101.xml · nonDerivative · entry 2

Dobek Maria · CIK 0002032671 · Vice President, Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,308

F3 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0002032671-26-000002 · form4-01022026_090101.xml · nonDerivative · entry 1

Dobek Maria · CIK 0002032671 · Vice President, Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,373

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · balance_after: Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025.

SEC source: 0002005618-26-000002 · form4-01022026_090110.xml · derivative · entry 3

DiRaimondo Thomas · CIK 0002005618 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,900

Underlying: Common Stock · 109,900 shares

Expires 2036-01-01

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0002005618-26-000002 · form4-01022026_090110.xml · nonDerivative · entry 2

DiRaimondo Thomas · CIK 0002005618 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,825

F3 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0002005618-26-000002 · form4-01022026_090110.xml · nonDerivative · entry 1

DiRaimondo Thomas · CIK 0002005618 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,425

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · balance_after: Includes 4,049 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on May 15, 2025. Also, on January 3, 2025, the Reporting Person filed a Form 4 which inadvertently reported an aggregate of 7,781 shares acquired under the Plan. In fact, 5,432 of the shares were already reported as acquired by the Reporting Person under the Plan on a Form 3 filed on January 3, 2024 and 1,406 of the shares were reported as acquired by the Reporting Person under the Plan on a Form 4 filed on September 27, 2024.

SEC source: 0001864159-26-000002 · form4-01022026_090112.xml · nonDerivative · entry 1

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,095

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

SEC source: 0001864158-26-000002 · form4-01022026_090108.xml · derivative · entry 3

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,100

Underlying: Common Stock · 338,100 shares

Expires 2036-01-01

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0001864158-26-000002 · form4-01022026_090108.xml · nonDerivative · entry 2

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,582

F2 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0001864158-26-000002 · form4-01022026_090108.xml · nonDerivative · entry 1

Campbell David Alan · CIK 0001864158 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,982

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

SEC source: 0001960264-26-000002 · form4-01022026_090107.xml · derivative · entry 3

Winter Charles M. · CIK 0001960264 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,100

Underlying: Common Stock · 100,100 shares

Expires 2036-01-01

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

SEC source: 0001960264-26-000002 · form4-01022026_090107.xml · nonDerivative · entry 2

Winter Charles M. · CIK 0001960264 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,321

F3 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.

SEC source: 0001960264-26-000002 · form4-01022026_090107.xml · nonDerivative · entry 1

Winter Charles M. · CIK 0001960264 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,721

F1 · kind: The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · balance_after: Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025.

SEC source: 0001864159-25-000006 · form4-12032025_081207.xml · derivative · entry 4

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,768

Underlying: Common Stock · 3,333 shares

Expires 2031-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001864159-25-000006 · form4-12032025_081207.xml · nonDerivative · entry 3

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,974

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.

F3 · price: The weighted average sale price for the transaction reported was $33.5247 and the range of prices were between $33.28 and $33.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0001864159-25-000006 · form4-12032025_081207.xml · nonDerivative · entry 2

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,607

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.

F2 · price: The weighted average sale price for the transaction reported was $32.8548 and the range of prices were between $32.27 and $33.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0001864159-25-000006 · form4-12032025_081207.xml · nonDerivative · entry 1

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001864159-25-000005 · form4-11142025_081103.xml · derivative · entry 3

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,101

Underlying: Common Stock · 3,333 shares

Expires 2031-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001864159-25-000005 · form4-11142025_081103.xml · nonDerivative · entry 2

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,974

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.

SEC source: 0001864159-25-000005 · form4-11142025_081103.xml · nonDerivative · entry 1

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1 share acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2024 and 2,834 shares acquired under the Plan on May 15, 2025.

SEC source: 0001864159-25-000003 · form4-10302025_081001.xml · derivative · entry 5

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,434

Underlying: Common Stock · 6,666 shares

Expires 2031-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001864159-25-000003 · form4-10302025_081001.xml · derivative · entry 4

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,333

Underlying: Common Stock · 9,999 shares

Expires 2031-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001864159-25-000003 · form4-10302025_081001.xml · nonDerivative · entry 3

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,139

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.

F2 · price: The weighted average sale price for the transaction reported was $30.0622 and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0001864159-25-000003 · form4-10302025_081001.xml · nonDerivative · entry 2

Meyer Andrew Hollman · CIK 0001864159 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.